In January 2015, former Food and Drug Administration (FDA) Commissioner David Kessler testified in a Philadelphia court that five years before Johnson & Johnson subsidiary Janssen Pharmaceuticals added warnings to its antipsychotic Risperdal regarding a side effect involving disfiguring breast growth in adolescent boys, the company was aware of its danger to minors. It was the first bellwether trial among thousands involving claims that Janssen tried to cover up Risperdal side effects. Kessler testified that Risperdal “probably or very likely” triggered breast growth in boys – a condition called gynecomastia. He backed up that claim by referencing a 2001 study ... Read More
Righting Injustice is published by the Beasley Allen Law Firm. If you are interested in a free legal consultation, please take a few moments to fill out the contact form with as many details as possible. The more information you provide us, the better we can evaluate your claim.